人瑞人才(06919.HK):修訂股份獎勵計劃
格隆匯 6 月 26日丨人瑞人才(06919.HK)公佈,於2020年6月26日,根據計劃規則的條款,董事會議決對計劃作出若干修訂並於同日生效,內容有關(其中包括)(i)獎勵的結算及/或支付;(ii)因終止僱傭及其他事項而不再為合資格人士;及(iii)計劃的限制,主要為採納於訂立信託契約後相應的變動。
同日宣佈,於2020年6月26日,公司已訂立信託契約並委任Trident Trust Company (HK) Limited作為受託人根據計劃規則管理計劃。受託人將根據計劃規則及信託契約管理計劃。董事會亦已決議向受託人支付總額不超過1億港元,用於根據計劃規則的條款在市場上購買公司現有股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.